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ABSTRACT 
It has been suggested that reflux laryngitis (RL) is involved in apneas-bradycardias of 
the newborn. The aim of the present study was to develop a unique RL model in 
newborn lambs in order to test the hypothesis that RL enhances the cardiorespiratory 
components of the laryngeal chemoreflexes (LCR) in the neonatal period. Gastric juice 
surrogate (2 mL HCl + pepsin, pH 2) (RL group, n = 6) or saline (Control group, n = 6) 
was repeatedly injected onto the posterior aspect of the larynx, 3 times a day for 6 
consecutive days, via a retrograde catheter introduced into the cervical esophagus. 
Lambs instilled with gastric juice surrogate presented clinical signs of RL, as well as 
moderate laryngitis on histological observation. Laryngeal chemoreflexes were 
thereafter induced during sleep by injection of 0.5ml of HCl (pH 2), milk, distilled water 
or saline into the laryngeal vestibule via a chronic, transcutaneous supra-glottal 
catheter. Overall, RL led to a significantly greater respiratory inhibition compared to the 
Control group during LCR, including longer apnea duration (p = 0.01), lower minimal 
respiratory rate (p = 0.002) and a more prominent decrease in SpO2 (p = 0.03). No 
effects were observed on cardiac variables. In conclusion, 1) our unique neonatal ovine 
model presents clinical and histological characteristics of RL; 2) the presence of RL in 
newborn lambs increases the respiratory inhibition observed with LCR, at times leading 
to severe apneas and desaturations. 
 
KEYWORDS: Polysomnography, sleep, apparent life-threatening event, apnea of 
prematurity, sudden infant death syndrome. 
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INTRODUCTION 
 
Laryngeal chemoreflexes (LCR) are a group of reflexes triggered in mammals by the 
contact between a liquid, such as milk or gastric juice, and receptors of the laryngeal 
mucosa. These reflexes, comprised of laryngeal closure, cough, swallowing (and 
arousal if necessary) in a mature organism, constitute a major protection mechanism 
against tracheal aspiration of liquids (20,21). However, in certain conditions, LCR can 
conversely be responsible for apneas, bradycardias and hypoxemia. The latter, while 
reminiscent of fetal-type LCR, can be so severe that they are likely responsible for a 
certain proportion of apneas of prematurity, most life-threatening events of infancy and 
some cases of sudden infant death syndrome (11,13,20,21,30). 
Gastric refluxes, especially laryngopharyngeal refluxes, are a very frequent and normal 
occurrence in the neonatal period. While most gastric refluxes in infants are weakly 
acid, mainly due to frequent feeds, it is nevertheless well documented that acid refluxes 
occur in infants. This includes healthy, preterm neonates (34 weeks postconceptional 
age), where a mean number of 16 acid laryngopharyngeal refluxes per day has been 
reported (17). In such cases, the acid-activated pepsin present in the refluxate can 
induce reflux laryngitis (RL) (1,12). 
Reflux laryngitis has been suggested to be one condition responsible for LCR with 
severe cardiorespiratory events in infants (31). However, evidence for the responsibility 
of RL in increasing the occurrence and severity of cardiorespiratory events during LCR 
is very weak. The main objective of our study was thus to compare LCR characteristics 
in RL lambs and control lambs, testing the hypothesis that increased cardiorespiratory 
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inhibition is present in RL lambs, as compared to controls. However, given that we were 
unable to find a neonatal RL model in the literature, a neonatal ovine RL model had to 
be designed beforehand in order to perform the study. 
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MATERIAL AND METHODS 
 
Animals 
A total of twelve newborn lambs, distributed equally into two groups (RL group and 
Control group), were included in this study. The study protocol was approved by the 
ethics committee for animal care and experimentation of our institution. 
 
Surgical instrumentation and recording equipment 
Surgical instrumentation 
Aseptic surgery was performed under general anesthesia (2% isoflurane, 30% N2O, 
68% O2) upon the day of arrival (postnatal day 1). Anesthesia was preceded by an 
intramuscular injection of ketamine (10 mg/kg), atropine sulfate (0.1 mg/kg) and 
morphine (0,016 ml/kg) and an intra-venous bolus (10 ml/kg) of Ringer’s lactate 
solution. One dose of ketoprofen (3 mg/kg) was also injected intramuscularly for 
analgesia and repeated if needed 12h later. Antibiotics (5 mg/kg gentamicin and 0.05 
ml/kg duplocilline) were administered intramuscularly prior to surgery and daily 
thereafter. Lambs were mechanically ventilated through an orotracheal tube (4.5 mm) 
throughout the surgical procedure. Bipolar platinum needle electrodes (made from F-E2 
needle-electrodes, Grass Technologies, West Warwick, RI, USA) were inserted into 
both thyroarytenoid muscles (TA; a glottal adductor) through the lateral aspect of the 
thyroid cartilage for electrical activity (EMG) recording. Both electrodes were then glued 
on the external surface of the thyroid cartilage. Two right-angled needle electrodes (E7-
12, Grass Technologies) were inserted into the parietal cortex directly through the skull, 
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at the level of the lambda suture, 1 cm from the midline, for electrocorticogram (ECoG) 
recording. A third needle electrode (F-E2M, Grass Technologies) was inserted under 
the scalp as a ground. Two platinum needle electrodes (F-E2, Grass Technologies) 
were also inserted subcutaneously into the outer lower and the inner upper region of the 
right eye socket for electrooculogram (EOG) recording. For electrocardiogram (ECG) 
recordings, two additional needle electrodes (F-E2M, Grass Technologies) were 
inserted under the periosteum of the 5th rib, on both sides of the thorax, and directly 
glued on the rib. A catheter was introduced into the right carotid artery to monitor arterial 
blood gases and arterial pressure. Leads from all electrodes were subcutaneously 
tunneled to exit on the back of the lambs. In addition, a supraglottal catheter was 
inserted transcutaneously to allow injection of liquids into the laryngeal vestibule, as 
previously described (6). Briefly, a 16 G infusion catheter was securely positioned such 
that its tip protruded 5-7.5 mm above the anterior part of the glottis. A plastic tubing 
(internal diameter 1 mm) was subcutaneously tunneled in the neck of the lamb and 
connected to the external part of the supraglottal catheter, which protruded 15-20 mm 
externally at the level of the anterosuperior aspect of the thyroid cartilage. Correct 
catheter positioning above the glottis was monitored throughout the insertion procedure 
by direct laryngoscopy. 
Finally, a retrograde catheter was introduced into the esophagus for reflux laryngitis 
induction (see below). After identification of the thyroid gland, the esophagus was 
exposed caudally over 10 cm to visualize the right recurrent laryngeal nerve trajectory. 
An 8 Fr Levine catheter connected to a trocar from a Hemovac drainage tube was 
introduced into the esophagus via the mouth of the lamb and exited by an incision in the 
7 
cervical esophagus wall, which avoided the recurrent laryngeal nerve. Under direct 
laryngoscopic visualization, the rostral extremity of the esophageal catheter was 
positioned 5 mm above the posterior rim of the larynx. The catheter was then secured to 
the cervical esophageal incision with biological glue, then sutured to the skin. The 
caudal part of the Levine catheter was finally subcutaneously tunneled to exit on the 
lamb’s back. 
 
Neonatal ovine model of reflux laryngitis  
A unique, chronic neonatal ovine model of reflux laryngitis was designed for the purpose 
of the present study. Following surgical instrumentation, lambs were randomly assigned 
to either the RL group or Control group. In the RL group, 2 ml of a solution containing 
pepsin (300 U/ml, Sigma-Aldrich Canada Ltd, Oakville, ON) and chlorohydric acid (HCl, 
pH 2.0) was instilled 3 times a day for 6 consecutive days using the esophageal 
catheter. Application of an acidified pepsin solution on the larynx to mimic an acid 
gastric reflux has been previously shown to induce laryngitis (1,12). In addition, our 
acidified pepsin solution was chosen to be representative of the gastric content of a 
newborn infant, whose pepsin concentration of gastric aspirates varies between 43 and 
683 U/ml in the neonatal period (M Armand, personal communication, Marseille, 
France). Meanwhile, lambs in the Control group were instilled with 2 ml of physiological 
saline 3 times a day for 6 consecutive days, via their esophageal catheter. 
Validation of our neonatal reflux laryngitis model was based on clinical signs and 
histological evaluation. Daily clinical follow-up included weighing of lambs and 
monitoring to detect the presence of chronic cough, difficulties to feed and altered 
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bleating. For the purpose of the study, a semi-quantitative score on a scale of 10 (with 
10 = 100% normal bleat, 9 = 90% normal bleat, ...) was used to evaluate altered 
bleating in each lamb and was assessed daily by the same observer. Correct 
positioning of the esophageal catheter was confirmed before euthanasia by direct 
laryngoscopy. Following euthanasia, the larynx was observed macroscopically for the 
presence of edema, ulceration and erythema. Finally, a pathologist expert in larynx 
assessment (AD) scored epithelial inflammation based on a scale used in a previous 
reflux laryngitis model. The glottis, epiglottis and first tracheal ring were scored on a 
scale of 15 depending on the worse criteria encountered for each following category: 
epithelial changes (intraepithelial inflammation, squamous metaplasia, erosion, 
ulceration) and subepithelial changes (stromal inflammation, periglandular inflammation 
and granulation or fibrosis) (12). 
 
Recording equipment 
Lamb instrumentation was completed immediately before recordings. Nasal flow was 
recorded from both nostrils using a double thermocouple wire (iron/constantan, type J; 
Omega Engineering, Stamford, CT) secured in an adapted dog muzzle. Rib cage and 
abdominal respiratory movements were also recorded by respiratory inductance 
plethysmography (Respitrace, Monitoring systems, Miami Beach, FL). A pulse oximeter 
sensor (Masimo Radical, Masimo, Irvine, CA) was attached at the base of the tail for 
continuous monitoring of arterial hemoglobin saturation (SpO2) and pulse wave. Finally, 
the subcutaneous plastic tubing connected to the supraglottal catheter was attached to 
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a custom-designed, radiotelemetry-driven injector, where the liquids to be injected were 
warmed and maintained at the lamb’s body temperature. 
In order to obtain data from prolonged recordings in non-sedated lambs, under the least 
possible restraining conditions, all leads from the EMG, EOG, ECoG and ECG 
electrodes, as well as nasal flow, were connected to our custom-designed radio 
telemetry transmitter (14). The pulse oximeter sensor was also connected to a second 
custom-designed radiotelemetry transmitter. The raw EMG signals were rectified, 
integrated and moving time averaged (100 ms). All parameters were continuously 
recorded using AcqKnowledge software (version 3.7.3, Biopac Systems, Santa Barbara, 
CA). In addition, an observer was continuously present to note all events occurring 
during recordings. 
 
Design of the study 
All lambs were housed with their mother in our animal quarters until experimental day. 
Following surgical instrumentation and RL induction, polysomnographic recordings were 
performed in non-sedated lambs on postnatal day 9 and 10 between 6:00 AM and 12:00 
PM. Lambs were placed in a Plexiglas chamber (1.2 x 1.2 x 1 m) and comfortably 
positioned on a mattress without contention during recordings. Laryngeal chemoreflexes 
were induced by random injection of 0.5 ml of saline (0.9% NaCl, pH = 5.5, osmolarity = 
326 mosM), distilled water (pH = 5.7), hydrochloric acid (HCl) diluted in saline (pH = 2, 
osmolarity = 295 mosM) and ewe milk (pH = 6.6, osmolarity = 298 mosM) via the 
supraglottal catheter. All four solutions were injected once in quiet sleep (QS) and once 
in active sleep (AS) on each experimental day (i.e., a total of 2 injections per solution 
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and per state of alertness). In addition, the supraglottal catheter was systematically 
flushed with 1 ml of saline between each injection of test solutions (dead space of the 
catheter 0.5 ml). Each animal was given at least 15 min of recovery time between two 
injections. Events such as agitation, cough, arousal and/or full awakening were noted by 
an observer throughout the recording sessions. Finally, following completion of the 
recordings, euthanasia was performed by an intravenous injection of 100 mg/kg of 
pentobarbital. Correct electrode and catheter positioning was systematically verified at 
autopsy. 
 
Data analysis 
States of alertness 
Standard electrophysiological and behavioral criteria were used to define sleep states 
(22). Cortical arousal from quiet sleep (QS) was defined by the association of a change 
in ECoG (decrease in amplitude + increase in frequency) for 3 seconds or more, with at 
least two of the following modifications: a 10% increase in heart rate (HR) or change in 
respiratory rate (RR) or movement (9). Arousal from active sleep (AS) was recognized 
by direct observation of the lamb and disappearance of intense EOG activity. Full 
awakening was defined when the lamb was still awake after 1 minute (7). 
 
Laryngeal chemoreflexes 
The main objective of the study was to assess the effect of RL on LCR. In addition, we 
queried whether this effect was different in QS vs. AS, and from one experimental 
solution to another. Analysis of the LCR was performed as described previously within 
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the first minute following each laryngeal injection (27). First, the cardiorespiratory 
responses were assessed as follows. The percentage of decrease in heart rate [%dec 
HR = (HRBL – HRmin)* 100/ HRBL] was calculated, with HRBL representing the baseline 
HR value averaged over 30 s before injection, and HRmin representing the minimal HR 
value observed after injection. The percentage of increase in mean arterial pressure, 
decrease in respiratory rate and decrease in transcutaneous oxygen saturation (SpO2) 
were calculated in the same manner. Any presence of bradycardia (defined by a %dec 
HR > 30%) was noted, and the number and total summed duration of bradycardias 
were tabulated. The number of apneas (defined as at least two missed breaths relative 
to baseline breathing) and total summed duration of apneas were recorded within the 
first minute after laryngeal stimulation. Respiratory LCR duration was measured as the 
time duration between the onset of the LCR and resumption of three consecutive 
breaths similar to baseline RR. In addition to cardiorespiratory responses, the number of 
swallows (recognized as a brisk, high-amplitude and short-duration TA EMG) was 
tallied. Total summed duration of TA EMG activity longer than 0.3 sec (considered as 
indicating laryngeal closure not related to the respiratory pause to accommodate 
swallowing) was calculated. The number of coughs (including laryngeal expiratory 
reflexes, which could not be discerned from coughs in our study) was also inferred from 
visual observation, as well as analysis of TA EMG and respiratory inductance 
plethysmograph signals. Finally, the presence of arousal or full awakening was noted. 
Statistical analysis 
Quantitative variables were expressed as mean ± SD, whereas qualitative variables 
(arousal and awakening) were expressed as relative frequency. Statistical analyses 
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were performed on raw data for all variables. The effect of RL was assessed for 
baseline physiological values by the Student’s t test. For the laryngeal chemoreflexes, 
quantitative variables were analyzed through a general linear model 3-way ANOVA for 
repeated measures using Proc mixed procedures (SAS software version 9.1.3, Cary, 
NC) with group, solutions and sleep states as the independent variables. Qualitative 
variables were analyzed with a logistic regression model. Differences were deemed 
significant if p < 0.05. In addition, given the relatively small number of studied lambs 
(related both to the complexity of the ovine model and ethical constraints), it was 
decided to give full consideration to the presence of a significant trend, defined as p < 
0.1. 
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RESULTS 
A total of 94 laryngeal stimulations were performed in the Control group (n = 6) [QS: 11 
saline, 12 distilled water, 12 HCl, 12 milk. AS: 12 saline, 11 distilled water, 12 HCl, 12 
milk] compared to 81 laryngeal stimulations in the RL group (n = 6) [QS: 12 saline, 11 
distilled water, 12 HCl, 12 milk. AS: 8 saline, 9 distilled water, 8 HCl, 9 milk].  
 
Reflux laryngitis group 
Clinical presentation of RL was variable from one lamb to the other. Hoarsened bleat 
(score over 7/10) at the end of the 6 days of instillation, up to absent bleating in 2 
lambs, was observed in 5/6 lambs from the RL group vs. 1/6 lambs in the Control lamb. 
Chronic cough was also observed in 2 lambs from the RL group. In addition, one lamb 
from the RL group, who presented cough during attempts at bottle-feeding and refused 
to feed, was tube-fed. Another RL lamb presented an apparent life-threatening event 
following simulated laryngopharyngeal refluxes and required manual stimulation and 
nasal administration of oxygen for a few minutes. Finally, a third RL lamb developed a 
recurrent neck extension with writhing movements of the limbs and an arched back 
following laryngopharyngeal refluxes (Sandifer syndrome). Overall, though variability 
was present within each group, the RL group presented more swallowing activities, 
coughing and agitation than the Control group at the time of simulated 
laryngopharyngeal refluxes. Mean weight gain was 190 ± 18 g per day for the Control 
group and 99 ± 67 g per day for the RL group (p = 0.05). 
Macroscopic assessment 
Macroscopic assessment of the larynx revealed the presence of ulcerations on the 
epiglottis and vocal cords in half of the RL group, compared to no such presence in any 
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of the control lambs. The presence of erythema on the posterior aspect of the vocal 
cords and edema was also noted in lambs in the RL group. 
Histological scoring of laryngeal inflammation 
Histological scoring of laryngeal inflammation was performed on 5 larynges in the RL 
group and 3 in the Control group (technical problems did not allow assessment of all 
larynges). Based upon histological criteria, a moderate laryngeal inflammation was 
induced in the RL group when compared to the Control group (4/15 ± 2/15 vs. 0/15 ± 
1/15). 
Baseline parameters 
Baseline parameter values obtained in each group are detailed in Table 1. Compared 
with the Control group, lambs in the RL group presented a lower baseline respiratory 
rate (41 ± 16 vs. 47 ± 10 min-1, p < 0.0001). No other significant differences were 
observed between Control and RL groups for baseline parameters. 
 
Effects of reflux laryngitis on laryngeal chemoreflexes 
Results obtained during laryngeal chemoreflexes (LCR) are summarized in Table 2 and 
detailed in Tables 3 and 4, including significant interactions. Overall, LCR elicited a 
significantly greater respiratory inhibition in the RL group compared to the Control group 
(all solutions and both sleep states taken together). This respiratory inhibition included a 
greater % decrease in RR, longer apnea duration, lower minimum respiratory rate and a 
more prominent decrease in SpO2 following LCR stimulation. In addition, apneas longer 
than 10 and 20 sec, as well as decreases in SpO2 greater than 10%, were more 
frequent in the RL group. Severe respiratory events were observed in one RL lamb 
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during LCR, with intense swallowing-related hypoventilation leading to a marked 
decrease in SpO2 down to 64% after milk and 54% after HCl (figure 1). While no overall 
significant differences were observed for cardiac parameters, including % of decrease in 
HR and bradycardia duration, the % of increase in mean arterial pressure was higher in 
the RL group than in the Control group. Finally, while no differences between groups 
were observed for arousal or awakening, a greater number of coughs and total duration 
of laryngeal closure, denoting enhanced lower airway protective mechanisms, was 
observed in the RL group. 
Regardless of the solution tested, no statistical interaction between group and sleep 
state was observed, indicating an absence of a sleep state effect on the differences 
between RL and Control groups. 
On the contrary, a significant interaction was observed between the type of solution and 
group of lambs, such that HCl triggered longer apnea duration in the RL as opposed to 
the Control group (respectively 13.2 ± 9.7 vs. 5.5 ± 7.8 sec, p = 0.0008). In fact, HCl 
triggered 7 of the 10 apneas longer than 20 seconds observed in the RL group. No 
other statistical interactions were observed between group and solution. 
Finally, several significant interactions between group, sleep state and type of solution 
were observed, including for minimal RR, % decrease in RR and % decrease in SpO2 
(see Table 3 for details). Overall, those interactions suggest that the effects of RL can 
be observed with any solution but saline, and independent of the sleep state. 
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DISCUSSION 
The present study provides novel findings on laryngeal chemoreflexes in a new, non-
sedated newborn lamb model of reflux laryngitis, which was developed for the purpose 
of the study. The relevance of this model is shown by clinical and/or histological signs of 
reflux laryngitis presented by all lambs. Overall, our findings reveal that the presence of 
reflux laryngitis in newborn lambs enhances the respiratory inhibition observed during 
laryngeal chemoreflexes. 
 
Our ovine neonatal model of reflux laryngitis 
An extensive review of the literature revealed that there are only a few animal models of 
RL. And while a total of 6 RL models have been described in adult rabbits, dogs or rats, 
no neonatal model, to our knowledge, has been previously described. In addition, most 
of these models were specifically designed to characterize the inflammation involved in 
subglottic stenosis on a traumatized larynx. (1,4,12,24). Only 2 models were designed 
to study an untraumatized larynx in mildly sedated adult rabbits or non-sedated adult 
rats (2,18). In contrast, our model was designed to closely reproduce clinical conditions, 
by posterior laryngopharyngeal instillations of a gastric juice surrogate (pepsin + HCl) in 
non-sedated newborn lambs. Parameters of our RL model were particularly chosen in 
order to reproduce what is observed in the neonatal period. A previous study showed 
that preterm infants are able to maintain an acidified gastric pH < 2, even at 24 weeks of 
gestational age (10). In addition, a recent study demonstrated that acidified gastric 
refluxes occur between feedings and, on average, represent 25% of all gastro-
esophageal refluxes observed per day in healthy preterm infants (17). Our acidified 
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pepsin solution was chosen to be representative of the gastric content of term newborns 
of 1-2 months (M Armand, personal communication, Marseille, France). 
Our neonatal ovine model accurately mimics clinical findings in RL, including cough, 
weak bleat and reduction in weight gain when compared to the Control group. Such 
subacute clinical manifestations were not reported in any of the previous studies cited, 
except for the presence of a biphasic stridor on exertion in rabbits with untraumatized 
larynx (18). While variable among lambs, simulated laryngopharyngeal refluxes with the 
gastric juice surrogate induced greater reactions in the RL group than in the Control 
group, even leading to an ALTE in one lamb. This lamb presented considerable clinical 
manifestations of RL, including unwillingness to feed. A previous study also showed that 
the response to simulated reflux was variable among individuals and also led to an 
ALTE in one adult animal (18). Our observations are consistent with the fact that, while 
laryngopharyngeal refluxes are present in virtually all infants, chronic consequences are 
very variable and only 1-2% will ultimately present with an ALTE (5). Further studies are 
hence needed in order to understand these individual variations and predispositions to 
an ALTE, which do not appear solely related to the degree of RL. 
 
Effect of reflux laryngitis on neonatal laryngeal chemoreflexes 
The present study confirms that RL influences neonatal LCR. More specifically, RL 
enhanced the respiratory inhibition observed during LCR, including longer apnea 
duration, lower minimum respiratory rate and a more prominent decrease in SpO2. 
Though this respiratory inhibition was most often moderate, severe respiratory events 
were observed in three RL lambs, which also presented with important clinical 
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manifestations. On the other hand, RL did not appear to enhance cardiac inhibition 
following LCR. Interestingly, a previous study in newborn lambs infected with the 
respiratory syncytal virus (16) showed an enhanced respiratory inhibition following LCR 
compared to controls, but no changes in cardiac parameters. Moreover, our recent 
study in full-term lambs exposed to cigarette smoke for the first 14 postnatal days 
showed a somewhat more significant respiratory than cardiac inhibition during LCR 
(28). However, other studies in lambs have shown that conditions, such as postnatal 
nicotine injection (29) and prematurity (27), can enhance both respiratory and cardiac 
inhibition during LCR. Providing a clear explanation for the different effects on the 
cardiac and respiratory components of the LCR in various conditions is not 
straightforward. Various mechanisms can be at play with regards to respiration and 
cardiac inhibition during LCR in lambs. For instance, while control of cardiac activity 
during LCR involves some level of sympatho-vagal co-activation (3), respiratory 
inhibition can in part be driven by the reciprocal inhibition brought about by intense 
swallowing activity (present results and 27). In fact, cardiac and respiratory activity 
during LCR likely results from a complex interaction of various mechanisms, which may 
depend on the offending condition. Conceivably, the latter, e.g. cigarette smoke 
exposure, RL, nicotine or prematurity, can variably alter the function of one or several 
components of the LCR loop, giving rise to variable consequences on cardiorespiratory 
components of the LCR. One hypothesis stems from the association between upper 
airway inflammation and increased cytokines in the brainstem, which in turn could 
enhance LCR-linked respiratory inhibition (15,30). Interestingly, increased cytokines in 
the brainstem have been reported in SIDS victims, compared to controls (8). 
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Aside from cardiorespiratory responses, our present study in full-term lambs did not 
reveal any alteration in swallowing activity or arousal in the RL group, whereas 
enhanced laryngeal closure and coughing were observed, all of which are important 
responses for liquid clearance from the laryngeal mucosa and prevention of tracheal 
aspiration. Previous observation of the blunting effect of premature birth on these airway 
protective mechanisms during LCR (27) suggests that the respiratory consequences of 
RL are likely worse in preterm neonates, as reported in infants (31). 
 
Influence of sleep states and the type of solution used to induce laryngeal 
chemoreflexes  
In the present study, no systematic effects of sleep states on LCR-related cardio-
respiratory events were observed. While such results may seem at variance with one 
study in lambs infected with respiratory syncytial virus (16), they are in agreement with 
other results obtained in preterm as well as in full-term lambs under various 
experimental conditions (19,27,28). 
In contrast, a systematic effect of HCl was observed herein, irrespective of the sleep 
state, such that the longest apnea duration in the RL group was specifically observed 
with HCl-triggered LCR. The fact that this was not the case in our previous studies 
(26,27,28) suggests that the apneic effect of HCl is specifically enhanced in the 
presence of RL. While this intriguing possibility requires further confirmation, it may be 
hypothesized that repeated exposure to HCl and/or pepsin during the 6 preceding days 
led to a specific sensitization of the laryngeal chemoreceptors, such as the C fiber 
endings (25). 
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Clinical implications 
Our results add further support to the suggestion that acid laryngopharyngeal refluxes 
can trigger clinically significant cardiorespiratory events in infants, up to an ALTE. In 
addition, enhancement of LCR-linked respiratory inhibition, especially by an acid 
solution, in the presence of RL, supports the involvement of laryngitis in certain 
cardiorespiratory events of preterm infants (31), and plausibly in some SIDS cases. 
Further studies combining the present RL model with our previous models of preterm 
lambs and/or lambs exposed to cigarette smoke are needed to better understand the 
importance of RL in the pathophysiology of apneas of prematurity, ALTE and SIDS. 
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FIGURE LEGENDS 
 
Figure 1: 
 
Laryngeal chemoreflexes triggered in a lamb with reflux laryngitis on postnatal day 9, 
following instillation of 0.5 ml of HCl onto laryngeal mucosa during active sleep. EEG, 
electroencephalogram; EOG, electrooculogram; TA, electrical activity of the 
thyroarytenoid muscle (a glottal constrictor muscle); nasal flow, nasal airflow; lung 
volume, sum signal of the respiratory inductance plethysmograph, allowing qualitative 
measurement of respiration (inspiration upward); ECG, electrocardiogram; HR, heart 
rate (beats/min); AP, arterial pressure; SpO2, oxygen hemoglobin saturation measured 
by pulse oximetry;  = cough. 
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TABLES 
 
 
Table 1: Influence of reflux laryngitis on baseline cardiorespiratory values 
 
Baseline values Control group Laryngitis group 
Heart rate (beats/min) 180 (23) 183 (30) 
Respiratory rate (breaths/min) 47 (10) 41 (16) 
Mean arterial pressure (mmHg) 73 (9) 75 (8) 
Hemoglobin O2 saturation (%) 97 (3) 97 (2) 
 
Values are expressed as mean (standard deviation). : p < 0.05 compared to 
Control group. All other p values are greater than 0.1 
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Table 2: Overall effects of reflux laryngitis on laryngeal chemoreflexes 
 
 Control group Laryngitis group P values 
% decrease HR 36 (17) 34 (19) 0.8 
Nb. of bradycardias 2 (4) 1 (3) 0.5 
Bradycardia duration (s) 1 (2) 1 (3) 0.9 
% increase MAP 19 (8) 25 (12)* 0.01 
Maximum MAP (mmHg) 87 (11) 94 (13) 0.2 
% decrease RR 62 (17) 65 (19)† 0.08 
Minimal RR (min-1) 17 (7) 13 (7)* 0.002 
Apnea duration (s) 5 (4) 9 (9)* 0.01 
% decrease SpO2 3 (3) 6 (8)* 0.04 
Minimum saturation (%) 94 (4) 91 (8)* 0.05 
Nb. of swallows 12 (9) 16 (12) 0.8 
Total duration of laryngeal closure (s) 0.3 (0.9) 1.4 (2.6) † 0.08 
Nb. of coughs 0.5 (1.4) 1.4 (3.0) † 0.1 
Arousal (yes/no) 80/12 68/12 0.8 
Awakening (yes/no) 49/43 34/46 0.4 
 
Quantitative variables are expressed as mean (SD) and qualitative variables (arousal 
and awakening) are expressed as relative frequency, with both sleep states and 
solution types taken together, for each group. Abbreviations: HR, heart rate; nb, 
number; MAP, mean arterial pressure; RR, respiratory rate; SpO2, hemoglobin O2 
saturation. * : p < 0.05; † : p < 0.1. 
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Table 3: Influence of sleep state and type of solution on the effects of reflux laryngitis on the cardiorespiratory 
components of laryngeal chemoreflexes 
 Quiet sleep Active sleep 
 Saline H2O HCl Milk Saline H2O HCl Milk 
% decrease HR         
     Control 31 (19) 40 (17) 36 (16) 38 (19) 35 (15) 33 (18) 36 (18) 37 (14) 
     Laryngitis 25 (16) 33 (20) 44 (19) 36 (21) 35 (22) 30 (11) 37 (15) 36 (23) 
Nb. of bradycardias         
     Control 1 (2) 2 (4) 2 (2) 4 (7) 1 (2) 2 (4) 2 (2) 2 (1) 
     Laryngitis 1 (1) 1 (1) 3 (5) 1 (2) 1(1) 1 (2) 2 (3) 1 (3) 
Bradycardia duration (s)         
     Control 1 (1) 1 (2) 1 (1) 3 (4) 1 (1) 1 (2) 1 (2) 1 (1) 
     Laryngitis 1 (1) 1 (1) 2 (4) 3 (5) 0.4 (0.4) 1 (1) 2 (2) 1 (3) 
% increase MAP         
     Control 12 (3) 20 (6) 20 (7) 18 (20) 18 (11) 17 (9) 20 (6) 24 (12) 
     Laryngitis 19 (9) 20 (9) 31 (14) 27 (15) 21 (13) 30 (14) 26 (14) 29 (5) 
% decrease RR         
     Control 56 (28) 67 (11) 65 (15) 51 (20) 57 (19) 69 (7) 61 (15) 66 (12) 
     Laryngitis 55 (21) 69 (18)* 69 (15)* 62 (16)* 52 (22) 73 (9)* 76 (17)* 68 (21) 
Minimum RR (min-1)         
     Control 18 (10) 14 (4) 15 (6) 21 (8) 20 (8) 15 (3) 17 (5) 15 (7) 
     Laryngitis 16 (7) 9 (4)* 11 (5)* 14 (6)* 22 (9) 12 (2)* 9 (5)* 12 (6) 
Apnea duration (s)         
     Control 5 (5) 6 (3) 7 (7) 2 (3) 4 (4) 5 (1) 4 (3) 5 (5) 
     Laryngitis 5 (6) 10 (7) 12 (8) 5 (4) 4 (7) 10 (7) 19 (28) 8 (8) 
% decrease SpO2         
     Control 2 (2) 3 (2) 6 (4) 3 (4) 2 (2) 2 (3) 3 (5) 2 (2) 
     Laryngitis 4 (5) 4 (2) 10 (8) 6 (6)* 4 (3) 6 (5)* 10 (14) 9 (10) † 
* : p < 0.05 and † : p < 0.1 RL vs. Control. All other p values are greater than 0.1. See table 2 for abbreviations. 
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Table 4: Influence of sleep state and type of solution on the effects of reflux laryngitis on the non-
cardiorespiratory components of laryngeal chemoreflexes 
 
 
 Quiet sleep Active sleep 
 Saline H2O HCl Milk Saline H2O HCl Milk 
Nb. of swallows         
     Control 6 (2) 13 (6) 21 (15) 11 (4) 6 (1) 10 (3) 17 (11) 12 (6) 
     Laryngitis 9 (6) 12 (3) 32 (17) 14 (5) 7 (2) 13 (7) 25 (12) 17 (9) 
Total duration of laryngeal closure (s)         
     Control 0 (0) 0 (0) 0.5 (1.4) 0.4 (1.0) 0.5 (1.0) 0 (0) 0.4 (1.0) 1 (1) 
     Laryngitis 1 (2) 0.7 (1.6) 1.6 (2.8) 1 (2) 0.4 (0.9) 2 (3) 2 (3) 3 (4) 
Nb. of coughs         
     Control 0 (1) 0 (1) 2 (3) 0 (1) 0 (0) 0 (0) 1 (2) 0 (0) 
     Laryngitis 1 (2) 1 (2) 4 (5) 1 (2) 0 (0) 1 (2) 2 (3) 1 (2) 
Arousal (yes/no)         
     Control 8/3 10/2 11/1 11/1 11/1 8/3 11/1 11/1 
     Laryngitis 10/2 10/1 11/1 11/1 5/3 7/2 8/0 7/2 
Awakening (yes/no)         
     Control 2/10 2/10 9/3 4/8 9/3 6/5 8/4 8/4 
     Laryngitis 3/9 3/7 6/6 4/8 3/5 3/6 7/1 5/4 
 
All values of p are greater than 0.1. See table 2 for abbreviations. 
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